FATE 8-K 2026-11-05

FATE THERAPEUTICS INC (FATE) 8-K dated 2026-11-05 — accession 0001193125-26-448530.

FATE THERAPEUTICS INC (FATE) is a biotechnology company listed on US.

FATE THERAPEUTICS INC filed a 8-K on 2026-11-05. Accession 0001193125-26-448530.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported FATE revenue for 2025-12-31 was $6.6M. Net income was -$136.3M. Revenue was down 51.2% from 2024-12-31 to 2025-12-31. FATE currently screens at market cap $331.0M.

Not investment advice. The FATE SEC hub lists recent forms. The stock page is the research view.